Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)

Clinical trial NCT00034697 · TERMINATED

Trial details

NCT number: NCT00034697
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastases, Neoplasm Carcinoma, Non-Small-Cell Lung Brain Neoplasms

Start date: 2001-06-28
Primary completion: 2003-01-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.